Piriformis Syndrome: Long-Term Follow-up in Patients Treated with Percutaneous Injection of Anesthetic and Corticosteroid Under CT Guidance
- نوع فایل : کتاب
- زبان : انگلیسی
- مؤلف : Salvatore Masala Sonia Crusco Alessandro Meschini Amedeo Taglieri Eros Calabria Giovanni Simonetti
- چاپ و سال / کشور: 2011
Description
Purpose This study was designed to evaluate the efficacy of CT-guided injection of anesthetic and corticosteroid for the treatment of pain in patients with piriformis syndrome unresponsive to conservative treatment. Methods Weenrolled 23 patients with piriformis syndrome, proposing a percutaneous intramuscular injection of methylprednisone- lidocaine. Among them, 13 patients accepted and 10 refused to undergo the procedure; the second group was used as a control group. Clinical evaluation was performed with four maneuvers (Lase`gue sign, FAIR test, Beatty and Freiberg maneuver) and a VAS questionnaire before the injection, after 5–7 days, and after 2 months. A telephonic follow-up was conducted to 3, 6, and 12 months. Results Procedural success was achieved in all patients who were treated without any complications. After 2 months, among 13 treated subjects, 2 of 13 patients showed positivity to FAIR test (hip flexion, adduction, and internal rotation), 2 of 13 were positive to Lase`gue sign, and the Beatty maneuver was positive in 1 patient. Patients who underwent conservative treatment were positive respectively in 7 of 10 (p = 0.01), 6 of 10 (p = 0.03), and 6 of 10 (p = 0.01). The VAS score showed a difference between patients treated with percutaneous approach and those managed with conservative therapy at the baseline evaluation (p = 0.04), after 2 months (p = 0.02), and 12 months (p = 0.002). We observed a significant reduction in pain for patients treated percutaneously, who were evaluated with the VAS scale at 5–7 days, 2 months, 3, 6, and 12 months (p\0.001). Conclusions Our findings suggested potential benefit from the percutaneous injection of anesthetics and corticosteroids under CT guidance for the treatment of piriformis syndrome.
Cardiovasc Intervent Radiol DOI 10.1007/s00270-011-0185-z Received: 19 November 2010 / Accepted: 9 May 2011
